Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 30518502

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2019 Jan
First author
Locke FL

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Jan;20(1):2-3. doi: 10.1016/S1470-2045(18)30900-8.
    note
    Source null
    related pmid
    30518503
    relationship
    Comment in

Authors and identifiers

  1. name
    Locke FL
    type
    Author
  2. name
    Ghobadi A
    type
    Author
  3. name
    Jacobson CA
    type
    Author
  4. name
    Miklos DB
    type
    Author
  5. name
    Lekakis LJ
    type
    Author
  6. name
    Oluwole OO
    type
    Author
  7. name
    Lin Y
    type
    Author
  8. name
    Braunschweig I
    type
    Author
  9. name
    Hill BT
    type
    Author
  10. name
    Timmerman JM
    type
    Author
  11. name
    Deol A
    type
    Author
  12. name
    Reagan PM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Locke FL
    type
    Author
  2. name
    Ghobadi A
    type
    Author
  3. name
    Jacobson CA
    type
    Author
  4. name
    Miklos DB
    type
    Author
  5. name
    Lekakis LJ
    type
    Author
  6. name
    Oluwole OO
    type
    Author
  7. name
    Lin Y
    type
    Author
  8. name
    Braunschweig I
    type
    Author
  9. name
    Hill BT
    type
    Author
  10. name
    Timmerman JM
    type
    Author
  11. name
    Deol A
    type
    Author
  12. name
    Reagan PM
    type
    Author
bibliography ids
  1. nci-bib-a0c16b7e3a9fb8040bd29f61
book metadata
content sha256
a94e9c876a40f6699141716ecf9c43f9dd14617d1634eaa2bbe2018857b31b47
document type
citation
dois
  1. 10.1016/S1470-2045(18)30864-7
electronic publication date
display
2018 Dec 2
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30518502
immutable id
pubmed:30518502@a94e9c876a40f6699141716ecf9c43f9dd14617d1634eaa2bbe2018857b31b47
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
1
name
The Lancet. Oncology
nlm unique id
100957246
pages
31-42
volume
20
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Jan;20(1):2-3. doi: 10.1016/S1470-2045(18)30900-8.
    note
    Source null
    related pmid
    30518503
    relationship
    Comment in
outcomes validated
false
pmid
30518502
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
a890f0e2903f0795e9a3e4515c8f3b29d97bbedf7923bcc940f2a9058cfa113e
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2019 Jan
precision
month
year
2019
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30518502/
title
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.

Preserved source evidence · Independent clinical review pending · Not medical advice